4-Amino-1-(1-Boc-pyrrolidin-3-yl)-1H-pyrazole, 97.0%, 25g

n-[(2,4-dimethoxyphenyl)methyl]pyrimidin-2-amine, 98%, 5g

2-desossi-D-galattosio, minimo 99%, per biochimica, 250 mg, confezione in vetro

(S)-tert-Butyl 4-(4-(4-(2-amino-3-methoxy-3-oxopropyl)phenoxy)butyl)piperidine-1-carboxylate, 97%, 1g

8-BROMO-6-METHYLIMIDAZO[1,2-A]PYRIDINE, 95.0%, 5g

Ethyl 4,8-dichloroquinoline-3-carboxylate, 95.0%, 10g

4,4'-(Ethane-1,2-diyl)bis(piperazine-2,6-dione), 98%, 1g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-fluoro-3-(trifluoromethyl)phenyl)propanoic acid, 98%, 1g

2'-thiomorpholinomethyl-3,4,5-trifluorobenzophenone, 97.0%, 1g

2-CHLORO-6-METHYL-1,5-NAPHTHYRIDINE, 95.0%, 250mg

Ethyl 2-aminopyrimidine-5-carboxylate, 95.0%, 25g

3,4,4-TRIFLUOROPIPERIDINE HCL, 95.0%, 250mg

7-Chloro-2-methyl-2H-indazole, 97%, 250mg